Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to 0.37.

  • Amphastar Pharmaceuticals' Debt Ratio fell 527.42% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 527.42%. This contributed to the annual value of 0.38 for FY2024, which is 216.64% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Debt Ratio is 0.37, which was down 527.42% from 0.38 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Debt Ratio high stood at 0.41 for Q3 2023, and its period low was 0.06 during Q2 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Debt Ratio value was 0.36 (recorded in 2023), while the average stood at 0.25.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Debt Ratio crashed by 2561.69% in 2021, and later surged by 29695.21% in 2023.
  • Amphastar Pharmaceuticals' Debt Ratio (Quarter) stood at 0.11 in 2021, then fell by 10.78% to 0.1 in 2022, then soared by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024, then fell by 4.12% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.38 for Q2 2025, and 0.37 during Q1 2025.